Market Cap 3.49B
Revenue (ttm) 75.13M
Net Income (ttm) -146.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -194.88%
Debt to Equity Ratio 0.00
Volume 7,707,242
Avg Vol 8,055,542
Day's Range N/A - N/A
Shares Out 306.61M
Stochastic %K 98%
Beta 1.20
Analysts Strong Sell
Price Target $16.12

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a researc...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 W 4th Avenue, Vancouver, Canada
Bullock3000
Bullock3000 Aug. 17 at 9:07 PM
$ABCL Thank you for building a bridge to understanding between Bulls and Bear.
0 · Reply
JiZzM0pper216
JiZzM0pper216 Aug. 17 at 9:01 PM
$ABCL the ai analyst's say the chart is over extended, we haven't even had a blow off top yet
1 · Reply
BiobankerPhD
BiobankerPhD Aug. 17 at 8:58 PM
$ABCL I see Bullock spamming the board and people dismissing them. But, they have rightly pointed out that the lack of immunogenicity (ADA) results is an open question for ABL635. In my experience, anti-drug antibodies (ADA) can absolutely kill a program, since ADA can result in rapid drug clearance or neutralize binding of your antibody to the target receptor. Both mechanisms can kill efficacy, and there is no effective mitigation for this. Which is why ADA assessment is critical in early phase studies to derisk development. My sense is that the Ph1/Ph2 results so far were from a single dose, so ADA results may come later with repeat dosing data. But still a significant unanswered question for 635.
1 · Reply
ShibWillow
ShibWillow Aug. 17 at 8:53 PM
Looks like Volume is shifting to MLEC now 🚀 MLEC has 573k shares remaining to public Look at what WETO / IPST did on similar share numbers today. MLEC getting squeezed now - Added a big position for a parabolic run! $NEON $LAC $QURE $ABCL adding!
1 · Reply
Gemology
Gemology Aug. 17 at 8:35 PM
0 · Reply
Money_maker777
Money_maker777 Aug. 17 at 8:17 PM
$ABCL After seven straight green days, a red day was bound to happen. We still held support, respected the trendline, and closed solid. A little consolidation here is healthy it lets the chart breathe before the next move. And yes, even though we closed lower, the uptrend is still intact. The structure didn’t break, momentum remains bullish.
0 · Reply
daytwister1
daytwister1 Aug. 17 at 8:06 PM
$ABCL As we closing the day : Stay wise and keep medium /long term hold to target +15 or more . Give weeks and couple months . Chance of break out 13$ is likely not for a matter of short days .
0 · Reply
Bullock3000
Bullock3000 Aug. 17 at 7:59 PM
$ABCL 😉Faux Phase 2. Director's wife trading the stock in her consulting company. No ADA or immunogenicity announcement. No new reads until October. Never produced a registered BLA after 14 years.
3 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 17 at 7:46 PM
$ABCL THIS is ALL YOU NEED to KNOW!! 👇🏻👇🏻
1 · Reply
DeMampCamp
DeMampCamp Aug. 17 at 7:45 PM
$ABCL We're up over 257% in the past 6 months, 83% in the last month, I'd be 100% ok with some consolidation. Give the RSI a breather, give us some time to build some solid support in the low $11S and then maintain this area until the next catalyst! Cheers all, happy Monday!
1 · Reply
Latest News on ABCL
AbCellera announces $200M common stock, warrants offering

2026-08-11T20:05:47.000Z - 6 days ago

AbCellera announces $200M common stock, warrants offering


AbCellera price target raised to $30 from $12 at Truist

2026-08-11T13:35:37.000Z - 6 days ago

AbCellera price target raised to $30 from $12 at Truist


AbCellera Biologics Slides: Corporate presentation

Aug 10, 2026, 8:00 AM EDT - 7 days ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Biologics Transcript: Study result

Aug 10, 2026, 7:30 AM EDT - 7 days ago

AbCellera Biologics Transcript: Study result


AbCellera Biologics Press release: Study result

Aug 10, 2026, 7:30 AM EDT - 7 days ago

AbCellera Biologics Press release: Study result


AbCellera Biologics Slides: Study result

Aug 10, 2026, 7:30 AM EDT - 7 days ago

AbCellera Biologics Slides: Study result


AbCellera price target raised to $9 from $8 at Stifel

2026-08-06T12:20:50.000Z - 11 days ago

AbCellera price target raised to $9 from $8 at Stifel


AbCellera Biologics Earnings Call Transcript: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 12 days ago

AbCellera Biologics Earnings Call Transcript: Q2 2026


AbCellera Biologics Slides: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 12 days ago

AbCellera Biologics Slides: Q2 2026


AbCellera Biologics Earnings release: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 12 days ago

AbCellera Biologics Earnings release: Q2 2026


AbCellera Biologics Quarterly report: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 12 days ago

AbCellera Biologics Quarterly report: Q2 2026


AbCellera Reports Q2 2026 Business Results

Aug 5, 2026, 4:05 PM EDT - 12 days ago

AbCellera Reports Q2 2026 Business Results


AbCellera upgraded to Buy from Hold at Benchmark

2026-07-07T10:35:14.000Z - 5 weeks ago

AbCellera upgraded to Buy from Hold at Benchmark

JAZZ


AbCellera apponts Lynn Seely to board of directors

2026-07-06T13:15:29.000Z - 6 weeks ago

AbCellera apponts Lynn Seely to board of directors

LYEL


AbCellera Appoints Dr. Lynn Seely to its Board of Directors

Jul 6, 2026, 9:00 AM EDT - 6 weeks ago

AbCellera Appoints Dr. Lynn Seely to its Board of Directors


AbCellera appoints Victor Sandor to board of directors

2026-06-05T13:05:56.000Z - 2 months ago

AbCellera appoints Victor Sandor to board of directors


AbCellera Appoints Dr. Victor Sandor to its Board of Directors

Jun 5, 2026, 9:00 AM EDT - 2 months ago

AbCellera Appoints Dr. Victor Sandor to its Board of Directors


AbCellera Biologics Earnings Call Transcript: Q1 2026

May 11, 2026, 5:00 PM EDT - 3 months ago

AbCellera Biologics Earnings Call Transcript: Q1 2026


AbCellera Biologics Earnings release: Q1 2026

May 11, 2026, 5:00 PM EDT - 3 months ago

AbCellera Biologics Earnings release: Q1 2026


AbCellera Biologics Quarterly report: Q1 2026

May 11, 2026, 5:00 PM EDT - 3 months ago

AbCellera Biologics Quarterly report: Q1 2026


AbCellera Biologics Slides: Q1 2026

May 11, 2026, 5:00 PM EDT - 3 months ago

AbCellera Biologics Slides: Q1 2026


AbCellera Biologics Slides: Corporate presentation

May 1, 2026, 8:00 AM EDT - 3 months ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 3 months ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 3 months ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera Biologics Earnings Call Transcript: Q4 2025

Feb 24, 2026, 5:00 PM EST - 6 months ago

AbCellera Biologics Earnings Call Transcript: Q4 2025


AbCellera Biologics Annual report: Q4 2025

Feb 24, 2026, 5:00 PM EST - 6 months ago

AbCellera Biologics Annual report: Q4 2025


AbCellera Biologics Earnings release: Q4 2025

Feb 24, 2026, 5:00 PM EST - 6 months ago

AbCellera Biologics Earnings release: Q4 2025


AbCellera Biologics Slides: Q4 2025

Feb 24, 2026, 5:00 PM EST - 6 months ago

AbCellera Biologics Slides: Q4 2025


AbCellera Reports Full Year 2025 Business Results

Feb 24, 2026, 4:05 PM EST - 6 months ago

AbCellera Reports Full Year 2025 Business Results


AbCellera Biologics Slides: Corporate presentation

Jan 14, 2026, 7:00 AM EST - 7 months ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 10, 2025, 9:00 AM EST - 10 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors


AbCellera Biologics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

AbCellera Biologics Earnings Call Transcript: Q3 2025


AbCellera Biologics Quarterly report: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

AbCellera Biologics Quarterly report: Q3 2025


AbCellera Biologics Earnings release: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

AbCellera Biologics Earnings release: Q3 2025


AbCellera Biologics Slides: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

AbCellera Biologics Slides: Q3 2025


AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 10 months ago

AbCellera Reports Q3 2025 Business Results


AbCellera Biologics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q2 2025


AbCellera Biologics Quarterly report: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q2 2025


AbCellera Biologics Earnings release: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q2 2025


AbCellera Biologics Slides: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q2 2025


AbCellera Biologics Slides: Corporate Presentation

Aug 1, 2025, 7:00 AM EDT - 1 year ago

AbCellera Biologics Slides: Corporate Presentation


AbCellera Biologics Earnings Call Transcript: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q1 2025


AbCellera Biologics Earnings release: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q1 2025


AbCellera Biologics Quarterly report: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q1 2025


AbCellera Biologics Slides: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q1 2025


AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2025 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q4 2024


AbCellera Biologics Earnings release: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q4 2024


AbCellera Biologics Annual report: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Annual report: Q4 2024


AbCellera Biologics Slides: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q4 2024


AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results


AbCellera Biologics Slides: FY 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

AbCellera Biologics Slides: FY 2025


AbCellera Biologics Earnings Call Transcript: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q3 2024


AbCellera Biologics Quarterly report: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Quarterly report: Q3 2024


AbCellera Biologics Earnings release: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q3 2024


AbCellera Biologics Slides: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q3 2024


AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results


Bullock3000
Bullock3000 Aug. 17 at 9:07 PM
$ABCL Thank you for building a bridge to understanding between Bulls and Bear.
0 · Reply
JiZzM0pper216
JiZzM0pper216 Aug. 17 at 9:01 PM
$ABCL the ai analyst's say the chart is over extended, we haven't even had a blow off top yet
1 · Reply
BiobankerPhD
BiobankerPhD Aug. 17 at 8:58 PM
$ABCL I see Bullock spamming the board and people dismissing them. But, they have rightly pointed out that the lack of immunogenicity (ADA) results is an open question for ABL635. In my experience, anti-drug antibodies (ADA) can absolutely kill a program, since ADA can result in rapid drug clearance or neutralize binding of your antibody to the target receptor. Both mechanisms can kill efficacy, and there is no effective mitigation for this. Which is why ADA assessment is critical in early phase studies to derisk development. My sense is that the Ph1/Ph2 results so far were from a single dose, so ADA results may come later with repeat dosing data. But still a significant unanswered question for 635.
1 · Reply
ShibWillow
ShibWillow Aug. 17 at 8:53 PM
Looks like Volume is shifting to MLEC now 🚀 MLEC has 573k shares remaining to public Look at what WETO / IPST did on similar share numbers today. MLEC getting squeezed now - Added a big position for a parabolic run! $NEON $LAC $QURE $ABCL adding!
1 · Reply
Gemology
Gemology Aug. 17 at 8:35 PM
0 · Reply
Money_maker777
Money_maker777 Aug. 17 at 8:17 PM
$ABCL After seven straight green days, a red day was bound to happen. We still held support, respected the trendline, and closed solid. A little consolidation here is healthy it lets the chart breathe before the next move. And yes, even though we closed lower, the uptrend is still intact. The structure didn’t break, momentum remains bullish.
0 · Reply
daytwister1
daytwister1 Aug. 17 at 8:06 PM
$ABCL As we closing the day : Stay wise and keep medium /long term hold to target +15 or more . Give weeks and couple months . Chance of break out 13$ is likely not for a matter of short days .
0 · Reply
Bullock3000
Bullock3000 Aug. 17 at 7:59 PM
$ABCL 😉Faux Phase 2. Director's wife trading the stock in her consulting company. No ADA or immunogenicity announcement. No new reads until October. Never produced a registered BLA after 14 years.
3 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 17 at 7:46 PM
$ABCL THIS is ALL YOU NEED to KNOW!! 👇🏻👇🏻
1 · Reply
DeMampCamp
DeMampCamp Aug. 17 at 7:45 PM
$ABCL We're up over 257% in the past 6 months, 83% in the last month, I'd be 100% ok with some consolidation. Give the RSI a breather, give us some time to build some solid support in the low $11S and then maintain this area until the next catalyst! Cheers all, happy Monday!
1 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 17 at 7:44 PM
$ABCL SO TRUE!
0 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 17 at 7:34 PM
$ABCL $12’s Let’s Go!
0 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 17 at 7:28 PM
$ABCL We ABOUT to TAKEOFF!!!
1 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 17 at 7:25 PM
$ABCL $11.60’s!! COMING RIGHT UP!!
0 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 17 at 7:21 PM
$ABCL BOOM! EXACTLY!
0 · Reply
SammyStocks22
SammyStocks22 Aug. 17 at 7:19 PM
$ABCL I’ve done some research since I saw this trending last week. I’m pretty bullish but what really got me is how they managed that offering. Couldn’t have done it better.
0 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 17 at 7:15 PM
$ABCL THIS is YOUR CHANCE NOW OR PAY MUCH MORE TOMORROW!!
0 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 17 at 7:11 PM
$ABCL HERE WE GO!! 12’s!!!
0 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 17 at 7:08 PM
$ABCL HERE Comes the SQUEEZE $12’s!!!
0 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 17 at 7:05 PM
$ABCL WHO WANT’s $12’s??!!!! COMING RIGHT UP!!!
0 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 17 at 7:02 PM
$ABCL STAY TUNED! It’s ABOUT to GET GOOD!! Get in NOW!!!
0 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 17 at 6:58 PM
$ABCL Let’s GO! POWER HOUR!! GET READY!!!
0 · Reply